Clinical Trial Results:
Effekten af forbehandling med 0.1 mg rekombinant human TSH (rhTSH) på glandula thyreoidea’s 131I-optagelse og graden af strumareduktion efter 131I-behandling, hos patienter med atoksisk multinodøs struma.
En prospektiv randomiseret dobbeltblindet undersøgelse.
Summary
|
|
EudraCT number |
2005-001078-29 |
Trial protocol |
DK |
Global completion date |
25 Jan 2010
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
15 Feb 2021
|
First version publication date |
15 Feb 2021
|
Other versions |
|
Summary report(s) |
Abstract to EudraCT_SJB_Afd. M_Odense University Hospital |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.